25236 Federal Register / Vol. 60, No. 91 / Thursday, May 11, 1995 / Notices

reader aids are included in the database

as ASCII text files, with graphics

provided in TIFF format. The online

Federal Register is available via the

Internet or as a dial-in service.

Historical data is available from January

1994 forward.

Other databases currently available

online through GPO Access include the

Congressional Record; Congressional

Record Index, including the History of

Bills; Congressional Bills; Public Laws;

U.S. Code; and GAO Reports.

Individuals interested in attending

may reserve a space by contacting John

Berger, Product Manager at the GPO’s

Office of Electronic Information

Dissemination Services, by telephone:

202–512–1525; by fax: 202–512–1262;

or by Internet e-mail at

john@eids05.eids.gpo.gov. Seating

reservations will be accepted through

Monday, May 22, 1995.

Michael F. DiMario,

Public Printer.

[FR Doc. 95–11612 Filed 5–10–95; 8:45 am]

BILLING CODE 1505–02–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substances and

Disease Registry

[ATSDR–94]

Notice of Availability of Administrative

Reports of Health Effects Studies

AGENCY: Agency for Toxic Substances

and Disease Registry (ATSDR), Public

Health Service (PHS), Department of

Health and Human Services (HHS).

ACTION: Notice.

SUMMARY: This notice announces the

availability of Administrative Reports of

nine ATSDR health effects studies.

FOR FURTHER INFORMATION CONTACT:

Jeffrey A. Lybarger, M.D., M.S., Director,

Division of Health Studies, Agency for

Toxic Substances and Disease Registry,

1600 Clifton Road, NE., Mailstop E–31,

Atlanta, Georgia 30333, telephone (404)

639–6200.

SUPPLEMENTARY INFORMATION: Sections

104(i)(1), (7), (8), and (9) of the

Comprehensive Environmental

Response, Compensation, and Liability

Act (CERCLA), as amended [42 U.S.C.

9604(i)(1), (7), (8), and (9)], provide the

Administrator of ATSDR with the

authority to conduct pilot studies,

epidemiologic and other health studies,

and to initiate health surveillance

programs to determine the relationship

between human exposure to hazardous

substances in the environment and

adverse health outcomes.

On February 13, 1990, ATSDR

published in the Federal Register [55

FR 5136] a final rule entitled, ‘‘Health

Assessments and Health Effects Studies

of Hazardous Substances Releases and

Facilities.’’ The primary purpose of that

rule, which created a new regulation at

42 CFR Part 90, was to set forth general

procedures that ATSDR will follow

relating to certain agency activities,

including the conduct of health effects

studies. Section 90.11 of the regulation,

which concerns the reporting of results

of health assessments and health effects

studies, provides that reports of health

effects studies conducted under section

104(i) of CERCLA will be available to

the general public upon request.

Availability

The reports of the health effects

studies listed below are now available

through the U.S. Department of

Commerce, National Technical

Information Service (NTIS), 5285 Port

Royal Road, Springfield, Virginia 22151,

telephone: 1–800–553–6847. There is a

charge for these items as determined by

NTIS.

Health effects study NTIS document No.

Soil-Related Lead Poisoning in

Socorro, New Mexico.

ATSDR/HS–94/36.

PB94–

193406

A Standardized Test Battery

for Lung and Respiratory

Diseases for Use in Environmental Health Field Studies.

ATSDR/HS–94/37.

PB94–

205556

Immune Function Test Batteries for Use in Environmental Health Field Studies.

ATSDR/HS–94/38.

PB94–

204328

National Exposure Registry

Policies and Procedures

Manual (Revised). ATSDR/

HS–95/39.

PB95–

154571

National Exposure Registry

Trichloroethylene (TCE)

Subregistry Baseline Technical Report (Revised).

ATSDR/HS–95/40.

PB95–

154589

Mortality Study of Children Residing Near ASARCO Copper Smelting in Ruston,

Washington. ATSDR/HS–95/

41.

PB95–

142022

Health Study to Assess the

Human Health Effects of

Mercury Exposure to Fish

Consumed from the Everglades. ATSDR/HS–95/42.

PB95–

167276

Health effects study NTIS document No.

Exposure to PCBs from Hazardous Waste Among Mohawk Women and Infants at

Akwesasne. ATSDR/HS–95/

43.

PB95–

159935

Jasper County, Missouri

Superfund Site Lead and

Cadmium Exposure Study.

ATSDR/HS–95/44.

PB95–

179404

In accordance with 42 CFR 90.11,

copies of these final reports have been

distributed to the Environmental

Protection Agency, the appropriate State

and local government agencies, and the

affected local communities.

ATSDR previously announced the

availability of 35 final reports of health

effect studies and a software package for

the analysis of disease clusters [55 FR

31445, August 12, 1990; 57 FR 29091,

June 30, 1992; 58 FR 29413, May 20,

1993; 58 FR 63378, December 1, 1993;

and 59 FR 47879, September 19, 1994].

Additional final reports will be

announced semiannually in the Federal

Register as they become available.

Dated: May 5, 1995.

Claire V. Broome,

Deputy Administrator, Agency for Toxic

Substances and Disease Registry.

[FR Doc. 95–11629 Filed 5–10–95; 8:45 am]

BILLING CODE 4163–70–P

Centers for Disease Control and

Prevention

[Announcement 550]

Enhancing Partnerships With Private

Sector Health Care Provider

Organizations; Notice of Availability of

Funds for Fiscal Year 1995

Introduction

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1995

funds for cooperative agreements to

enhance partnerships with private

sector health care provider

organizations and to promote the

improvement of immunization coverage

in primary care settings.

The Public Health Service (PHS) is

committed to achieving the health

promotion and disease prevention

objectives of Healthy People 2000, a

PHS-led national activity to reduce

morbidity and mortality and improve

the quality of life. This announcement

is related to the priority areas of

Immunization and Infectious Diseases.

(To order a copy of Healthy People

2000, see the section Where to Obtain

Additional Information.)
Federal Register / Vol. 60, No. 91 / Thursday, May 11, 1995 / Notices 25237

Authority

This program is authorized under the

Public Health Service Act, Sections 301

[42 U.S.C. 241] and 317 [42 U.S.C.

247b], as amended.

Smoke-Free Workplace

PHS strongly encourages all grant

recipients to provide a smoke-free

workplace and to promote the nonuse of

all tobacco products, and Public Law

103–227, the Pro-Children Act of 1994,

prohibits smoking in certain facilities

that receive Federal funds in which

education, library, day care, health care,

and early childhood development

services are provided to children.

Eligible Applicants

Eligible applicants for this program

are national private sector health care

provider organizations and associations

with an active membership of at least

2500 health care providers.

Availability of Funds

Approximately $500,000 is available

in FY 1995 to fund up to seven awards.

The average award will range from

$75,000 to $150,000. Awards will begin

on or about September 1, 1995, and will

be made for 12 month budget periods

within a project period of up to 5 years.

Funding estimates outlined above may

vary and are subject to change.

Continuation awards within the

approved project period will be made

on the basis of satisfactory progress, an

acceptable application, and the

availability of funds.

Purpose

The purpose of this cooperative

agreement is:

1. To establish partnerships with

national private provider organizations

and associations to effectively utilize

the combined resources of the public

and private health care delivery

systems.

2. To meet the immunization

objectives established by the Secretary

of the Department of Health and Human

Services. Priority will be given to those

activities likely to result in increased

immunization levels among children 24

months of age and reduction/

elimination of targeted vaccinepreventable diseases by 1996.

Program Requirements

In conducting activities to achieve the

purpose of this program, the recipient

will be responsible for the activities

under A. (Recipient Activities), and

CDC will be responsible for the

activities listed under B. (CDC

Activities).

A. Recipient Activities

1. Develop and Implement

Immunization Initiatives: Recipients

must develop and implement among

their constituencies a plan to enhance

the delivery of immunization services

through implementing the —Standards

for Pediatric Immunization Practices—,

implementing provider self assessment

activities, developing incentives for

providers to improve coverage,

implementing reminder/recall systems,

and developing and implementing

creative and innovative activities.

2. Develop an evaluation plan to

monitor progress toward achieving their

objectives.

B. CDC Activities

1. Provide technical assistance to

plan, implement, and evaluate each

component of the plan to enhance

delivery of immunization services.

2. Assist in interpretation of current

scientific literature related to methods

to improve immunization coverage

levels.

3. Provide assistance in the evaluation

of each plan component (process and

outcome) through the analysis and

interpretation of coverage and other

relevant data.

Evaluation Criteria

The application will be evaluated

according to the following criteria:

A. Background and Need: The extent

to which the applicant understands the

problem of underimmunization and

proposes a plan to address the issues

specific to their constituents. (20 points)

B. Operational Plan: The feasibility

and appropriateness of the applicant’s

operational plan to enhance

immunization services delivery among

constituencies through implementing

the ‘‘Standards for Pediatric

Immunization Practices’’, implementing

provider self-assessment activities,

developing incentives for providers to

improve coverage, implementing

reminder/recall systems, and

developing and implementing creative

and innovative activities. (45 points)

C. Coordination with Public Sector

Activities: The extent to which the

applicant proposes to coordinate

activities with State and local

immunization programs and other

appropriate agencies as evidenced by

letters of support. (5 points)

D. Capability: The extent to which the

applicant appears likely to succeed in

implementing proposed activities as

measured by (1) Relevant past

experiences; (2) feasible program

objectives; (3) a realistic timetable for

plan implementation; (4) a sound

management structure; and (5) the

qualifications of staff, including the

appropriateness of their proposed roles

and responsibilities or job descriptions.

(30 points)

E. Budget and Justification: The extent

to which the proposed budget is

adequately justified, reasonable, and

consistent with this program

announcement. (Not weighted)

Executive Order 12372

This program is not subject to the

Intergovernmental Review of Federal

Programs as governed by Executive

Order 12372.

Public Health System Reporting

Requirements

This program is not subject to the

Public Health System Reporting

Requirements.

Catalog of Federal Domestic Assistance

Number

The Catalog of Federal Domestic

Assistance Number is 93.268.

Other Requirements

Paperwork Reduction Act

Projects that involve the collection of

information from 10 or more individuals

and funded by this announcement

(#550) will be subject to review by the

Office of Management and Budget

(OMB) under the Paperwork Reduction

Act.

Application Submission and Deadline

The original and two copies of the

application PHS Form 5161–1, (OMB

Number 0937- 0189) must be submitted

to Henry S. Cassell, III, Grants

Management Officer, Attn: Lisa

Tamaroff, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Mailstop E13, Atlanta, GA 30305, on or

before July 10, 1995.

1. Deadline

Applications shall be considered as

meeting the deadline if they are either:

A. Received on or before the deadline

date; or

B. Sent on or before the deadline date

and received in time for submission for

the review process. Applicants should

request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

or U.S. Postal Service. Private metered

postmarks shall not be acceptable proof

of timely mailing.

2. Late Applications

Applications which do not meet the

criteria in 1.A. or 1.B. above are
25238 Federal Register / Vol. 60, No. 91 / Thursday, May 11, 1995 / Notices

considered late applications. Late

applications will not be considered in

the current competition and will be

returned to the applicant.

Where To Obtain Additional

Information

Information on application

procedures, copies of application forms,

and other materials may be obtained

from Lisa Tamaroff, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Mailstop E13, Atlanta, GA 30305,

telephone (404) 842–6796.

Please refer to Announcement

Number 550 when requesting

information and submitting an

application.

Programmatic technical assistance

may be obtained from William A.

Murrain, Immunization Services

Division, National Immunization

Program, Centers for Disease Control

and Prevention (CDC), 1600 Clifton

Road, Mailstop E52, Atlanta, GA 30333,

telephone (404) 639–8208.

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report; Stock No. 017–001–00474–0) or

Healthy People 2000 (Summary Report;

Stock No. 017–001- 00473–1) through

the Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325, telephone

(202) 512–1800.

Copies of the ‘‘Standards for Pediatric

Immunization Practices’’ may be

obtained from the National

Immunization Program, Immunization

Services Division, Centers for Disease

Control and Prevention (CDC), Mailstop

E–34, 1600 Clifton Road, NE., Atlanta,

GA 30333, telephone (404) 639–8225.

Dated: May 5, 1995.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 95–11624 Filed 5–10–95; 8:45 am]

BILLING CODE 4163–18–P

Injury Research Grant Review

Committee: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Injury Research Grant Review

Committee (IRGRC).

Times and Dates: 6 p.m.–9 p.m., June 4,

1995; 8 a.m.–5 p.m., June 5, 1995; 8 a.m.–12

noon, June 6, 1995.

Place: Wyndham Garden Hotel-Midtown,

125 10th Street, NE, Atlanta, Georgia 30309.

Status: Open: 6 p.m.–7 p.m., June 4, 1995;

closed: 7 p.m.–9 p.m., June 4, 1995, through

12 noon, June 6, 1995.

Purpose: This committee is charged with

advising the Secretary of Health and Human

Services, the Assistant Secretary for Health,

and the Director, CDC, regarding the

scientific merit and technical feasibility of

grant applications relating to the support of

injury control research and demonstration

projects and injury prevention research

centers.

Matters to be Discussed: Agenda items for

the meeting will include announcements,

discussion of review procedures, future

meeting dates, and review of grant

applications.

Beginning at 7 p.m., June 4, through 12

noon, June 6, the committee will meet to

conduct a review of grant applications. This

portion of the meeting will be closed to the

public in accordance with provisions set

forth in section 552b(c) (4) and (6), title 5

U.S.C., and the Determination of the

Associate Director for Management and

Operations, CDC, pursuant to Pub. L. 92–463.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Richard W. Sattin, M.D., Executive Secretary,

IRGRC, National Center for Injury Prevention

and Control, CDC, 4770 Buford Highway, NE,

Mailstop K58, Atlanta, Georgia 30341–3724,

telephone 404/488–4580.

Carolyn J. Russell,

Director, Management Analysis and Services

Officer, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–11625 Filed 5–10–95; 8:45 am]

BILLING CODE 4163–18–M

National Institutes of Health

Notice of Meeting of the Advisory

Committee to the Director, NIH

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

Advisory Committee to the Director,

NIH, May 31, 1995, Conference Room

10, Building 31, National Institutes of

Health, Bethesda, Maryland 20892.

The entire meeting will be open to the

public from 10:00 a.m. to adjournment.

The topics proposed for discussion

include (1) Report on the Structure and

Function of the Division of Research

Grants; (2) Views from the NIH Basic

Research Ombudsman and the NIH

Clinical Research Emissary; (3) REGO

II—Study of the Clinical Center; and (4)

New Affirmative Action Plan.

Attendance by the public will be limited

to space available.

Ms. Janice Ramsden, Program

Assistant, Office of the Deputy Director,

National Institutes of Health, 1 Center

Drive MSC 0159, Bethesda, Maryland

20892–0159, telephone (301) 496–0959,

fax (301) 496–7451, will furnish the

meeting agenda, roster of committee

members, and substantive program

information upon request. Any

individual who requires special

assistance, such as sign language

interpretation or other reasonable

accommodations, should contact Ms.

Ramsden no later than May 24, 1995.

Dated May 5, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–11596 Filed 5–10–95; 8:45 am]

BILLING CODE 4140–01–M

John E. Fogarty International Center

for Advanced Study in the Health

Sciences; Meeting of the Fogarty

International Center Advisory Board

Pursuant to Pub. L. 92–463, notice is

hereby given of the thirtieth meeting of

the Fogarty International Center (FIC)

Advisory Board, May 23, 1995, in the

Lawton Chiles International House

(Building 16), at the National Institutes

of Health.

The meeting will be open to the

public from 8:30 a.m. to noon. In

addition to a report by the Director, FIC,

and a report on the Science Leadership

Exchange that was recently sponsored

by the White House Office of Science

and Technology Policy, the agenda will

focus on new and emerging infectious

diseases which result from ecological

changes and population patterns. In

addition to naturally evolving disease

pathogens, the agenda also will address

manufactured pathogens and research

issues related to biological weapons.

In accordance with the provisions of

Secs. 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. and sec. 10(d) of Pub. L. 92–463,

the meeting will be closed to the public

from 1:15 p.m. to adjournment for the

review of applications to the

International Research Fellowship and

Senior International Fellowship

Programs; Fogarty International

Research Collaboration and HIV, AIDS

and Related Illnesses Collaboration

Awards; nominations to the Scholars-inResidence Program; and proposals for

Scholar’s conferences.

Paula Cohen, Committee Management

Officer, Fogarty International Center,

National Institutes of Health, Building

31, Room B2C08, 31 CENTER DR MSC

2220, Bethesda, Maryland 20892–2220,

telephone: 301–496–1491, will provide

a summary of the meeting and a roster

of the committee members upon

request.

Irene Edwards, Executive Secretary,

Fogarty International Center Advisory

Board, Building 31, Room B2C08,

telephone: 301–496–1491, will provide

substantive program information.